Evidence map›Paper›PMID 28106559›Full record

ArticleJournal of Alzheimer's disease : JAD2017

ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice.

Nicholas F Fitz, Alexis Y Carter, Victor Tapias, Emilie L Castranio, Ravindra Kodali, Iliya Lefterov, Radosveta Koldamova

Open access · hybridAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Listerin Alleviates Alzheimer's Disease through IRE1-mediated Decay of TLR4 mRNA.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. The Role of the ATP-Binding Cassette A1 (ABCA1) in Human Disease.International journal of molecular sciences · 2021
    Review
  13. Article
  14. Article
  15. Article
  16. Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective.International journal of molecular sciences · 2019
    Review
  17. Review
  18. Article
  19. Relationship betweenExperimental and therapeutic medicine · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nicholas F FitzDepartment of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Alexis Y CarterDepartment of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Victor TapiasDepartment of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Emilie L CastranioDepartment of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Ravindra KodaliDepartment of Structural Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
Iliya LefterovDepartment of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Radosveta KoldamovaDepartment of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
University of Pittsburgh · US

Funding

Epigenetic and phenotypic effects of arsenic: impacts on cognition and ADR01ES024233 · NIEHS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLDAMOVA, RADOSVETA, LEFTEROV, ILIYA · 2014 to 2018
$2.6M
Genome wide analysis of LXR binding - metabolic and epigenetic regulation in ADR01AG037919 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LEFTEROV, ILIYA, SCHUG, JONATHAN · 2012 to 2016
$2.4M
LXR and human ApoE isoform effects on AD phenotype: in vitro and in vivo modelsR01AG037481 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLDAMOVA, RADOSVETA · 2011 to 2015
$1.8M
Peripheral & Brain Cholesterol Metabolism in Neurodegenerative Mouse ModelsK01AG044490 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FITZ, NICHOLAS FRANCIS · 2014 to 2018
$463k
NIA NIH HHS K01 AG044490NIA NIH HHS R01 AG037481NIA NIH HHS R01 AG037919NIEHS NIH HHS R01 ES024233
6 · The paper itself

Abstract

ATP-binding cassette transporter A1 (ABCA1) mediates cholesterol efflux to lipid-free apolipoproteins and regulates the generation of high density lipoproteins. Previously, we have shown that lack of Abca1 significantly increases amyloid deposition and cognitive deficits in Alzheimer's disease model mice expressing human amyloid-β protein precursor (APP). The goal of this study was to determine if ABCA1 plays a role in memory deficits caused by amyloid-β (Aβ) oligomers and examine neurite architecture of pyramidal hippocampal neurons. Our results confirm previous findings that Abca1 deficiency significantly impairs spatial memory acquisition and retention in the Morris water maze and long-term memory in novel object recognition of APP transgenic mice at a stage of early amyloid pathology. Neither test demonstrated a significant difference between Abca1ko and wild-type (WT) mice. We also examined the effect of intra-hippocampal infused Aβ oligomers on cognitive performance of Abca1ko mice, compared to control infusion of scrambled Aβ peptide. Age-matched WT mice undergoing the same infusions were also used as controls. In this model system, we found a statistically significant difference between WT and Abca1ko mice infused with scrambled Aβ, suggesting that Abca1ko mice are vulnerable to the effect of mild stresses. Moreover, examination of neurite architecture in the hippocampi revealed a significant decrease in neurite length, number of neurite segments, and branches in Abca1ko mice when compared to WT mice. We conclude that mice lacking ABCA1 have basal cognitive deficits that prevent them from coping with additional stressors, which is in part due to impairment of neurite morphology in the hippocampus.

Indexed as

Amyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsATP Binding Cassette Transporter 1Cell SizeCognition DisordersDendritesFemaleHippocampusHumansMaleMaze LearningMice, Inbred C57BLMice, TransgenicPresenilin-1Recognition, PsychologyAbca1 protein, mouseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAPP protein, humanATP Binding Cassette Transporter 1Presenilin-1PSEN1 protein, humanAlzheimer’s diseaseamyloid-β oligomersAPP miceATP-binding cassette transporter A1 (Abca1)behaviorhippocampal infusionneurite morphologyradial arm water maze

Identifiers

PMID28106559
PMCPMC5302049
OpenAlexW2573415848

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.